AnalysIs of molecular mechanism of gastric pre-cancerous lesions by using new mucin genes

新粘蛋白基因分析胃癌前病变的分子机制

• 批准号: 09470141
• 负责人: IMAI Kohzoh
• 金额: $ 2.18万
• 依托单位: Sapporo Medical University
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Scientific Research (B)
• 财政年份: 1997
• 资助国家: 日本
• 起止时间: 1997 至 1998
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-09470141/
• 关键词: mucin genes; gastric pre-cancerous lesions; Intestinal metaplasia; gastric cancer; Barett esohagus; 分子機構解析

Our previous study showed that a new mucin antigen A3D4 was expressed at the protein level in gastric cancer and intestinal metaplasia associated with cancer, but not in normal gastric mucosa and intestinal metaplasia with chronic gastritis. To verify if the antigen is of use for diagnostic purpose, we performed an immunohistochemical study using a large number of gastric tissue specimens obtained by endoscopic biopsy. Antigen A3D4 was expressed in adenoma, especially intestinal type with high frequency and in intestinal metaplasia in the vicinity of adenoma. Of note, about 20% of intestinal metaplasia with chronic gastritis cases demonstrated to be positive for antigen A3D4, where only part of the deep portion of glands were faintly immunostained. These data suggest that antigen A3D4-positive intestinal metaplasia cases may be grouped into a high risk group for gastric adenoma and cancer.It is known that MUC2 mucin is expressed in goblet cells of intestinal metaplasia, but not in normal gastric mucosa. We revealed that MUC2 was expressed in regenerative epithelia and gastric cancer, especially intestinal type, in addition to intestinal metaplasia. It will be important to examine the expression of MUC2 in the background mucosa of gastric cancer except for intestinal metaplasia. We then showed the expression of sulfo-Lewis A, which was shown expressed on MUC2 mucin core protein, in Barrette*s esophagus and esophageal adenocarcinoma by using a monoclonal antibody 91.9H.Thus, these two antigens, MUC2 and sulfo-Lewis A may be of use for analyzing the precancerous lesions of the stomach and esophagus, respectively.

本实验室前期研究发现，一种新的粘蛋白抗原A3 D4在胃癌及癌旁肠化组织中有蛋白水平的表达，而在正常胃粘膜及慢性胃炎肠化组织中无表达。为了验证该抗原是否可用于诊断目的，我们使用通过内镜活检获得的大量胃组织标本进行了免疫组织化学研究。A3 D4抗原在腺瘤中表达，尤其是肠型腺瘤和腺瘤旁肠上皮化生中表达频率较高。值得注意的是，约20%的慢性胃炎肠上皮化生病例显示抗原A3 D4阳性，其中只有部分腺体深部免疫染色微弱。这些数据表明，抗原A3 D4阳性的肠化病例可能被归为胃腺瘤和胃癌的高危组。MUC 2粘蛋白在肠化的杯状细胞中表达，而在正常胃粘膜中不表达。我们发现MUC 2在再生上皮和胃癌中表达，尤其是肠型胃癌，除肠上皮化生外。因此，检测MUC 2在除肠上皮化生以外的胃癌背景粘膜中的表达具有重要意义。用单克隆抗体91.9H检测了MUC 2核心蛋白上的sulfo-Lewis A在Barrette食管和食管腺癌中的表达，表明MUC 2和sulfo-Lewis A可分别用于分析胃癌和食管癌前病变。

项目成果

Yamamoto, H., et al.: "Relation of enhanced secretion of active matrix metalloproteases with tumor spread in human hepatocellular carcinoma." Gastroenterology. 112. 1290-1296 (1997)

Yamamoto, H. 等人：“活性基质金属蛋白酶分泌增强与人肝细胞癌肿瘤扩散的关系。”

Takaoka,A.,et al.: "Anti-cell death activity promotes pulmonary metastasis of melanoma cells." Oncogene. 14. 2971-2977 (1997)

Takaoka,A.,et al.：“抗细胞死亡活性促进黑色素瘤细胞的肺转移。”

Shinoda,M.et al.: "Effective adoptive immunotherapy by T-LAK cells retargeted with bact-erial superantigen-conjugated antibody to MUC1 in xenografted SCID mice." Cancer Res.58. 2838-2843 (1998)

Shinoda,M.等人：“在异种移植 SCID 小鼠中，通过细菌超抗原偶联的 MUC1 抗体重新靶向 T-LAK 细胞，进行有效的过继免疫治疗。”

Suwa,T.et al.: "Increased invasiveness of MUC1 cDNA-transfected human gastric cancer MKN74 cells." Int.J.Cancer. 76. 377-382 (1998)

Suwa,T.et al.：“MUC1 cDNA 转染的人胃癌 MKN74 细胞的侵袭性增加。”

Yoshida,Y.et al.: "Development of the arbitrarily primed-representational difference analysis(AP-RDA)method and chromosomal mapping of isolated high throughput rat genetic markers." Proc.Natl.Acad.Sci.USA. in press. (1999)

Yoshida,Y.et al.：“任意引物代表性差异分析 (AP-RDA) 方法的开发和分离的高通量大鼠遗传标记的染色体作图。”